Great article on why evidence of benefit is so important. Ideally before FDA/CDRH Industry approval and clinical use (for #SCS ). #UCSFproud A JAMA Network sweep here!

Can you believe that only 2% of old venture capital funding goes to companies started by women? Data shared in this amazing discussion about the importance of women’s health for all..

Severe underinvestment in companies started by women! Was 2%, now is 1%!! nytimes.com/2024/09/21/bus…

So #UCSFproud of my colleagues and their important work to protect women’s health. Kathryn A Phillips PhD

So well deserved! Generous and incredibly energetic and kind mentor to so many.

What a powerhouse of inspirational women leaders!

Great to see my old colleagues and meet new ones . #CircCQO ⁦Brahmajee Nallamothu⁩ ⁦⁦Ritu Thamman MD⁩ dennisko

Agree, Ade! But no doubt profitable. Just not good for patients. We should not be screening for CAD, nothing good comes from it.

Waiting for the NIH Director confirmation hearing to begin with my UCDC Health Policy students. Thank you U.S. Senator Bill Cassidy, M.D.

QUOTE OF THE DAY: "People still think Elvis is alive.” -- U.S. Senator Bill Cassidy, M.D. to NIH nominee Jay Bhattacharya, on why funding more research into whether vaccines cause autism is a waste of $$ and will not change any minds. w/Benjamin Mueller nytimes.com/2025/03/05/us/…

Happy International Women’s Day!! Never forget your #worth, #value, #strength,#intelligence,#impact, #influence #power We got this! Let’s celebrate today You deserve it all!! Keep Climbing and Stay #Strong and #United Women As One #WIC American College of Cardiology American Heart Association European Society of Cardiology

#Smithsonian

Our paper in The Lancet Reg Health-Americas Barriers and solutions in women’s health research and clinical care: a call to action Barbra Streisand Women's Heart Center Cedars-Sinai Smidt Heart Institute at Cedars-Sinai Cedars-Sinai Academic Medicine Judy Regensteiner Ludeman Center Stacey Rosen, M.D. Hadine Joffe Rita Redberg Stephanie Faubion 📎sciencedirect.com/science/articl…

The curse of the 80% Pers AF-free curse of non-randomized trials lives on in the PFA era. #EHRA2025

Patients lives don’t stop for a blanking period. pmc.ncbi.nlm.nih.gov/articles/PMC11… Andrew Foy Mohammed Ruzieh, MD It’s time to jettison the blanking period altogether #ACC25 #ehra25

✨Premarket approval: highest evidence requirement but lacking- no randomization, use of surrogate endpoints ✨very few sham comparison of devices ✨510k premarket notification- just had to show equivalence and is not intended to evaluate safety or effectiveness Rita Redberg

well said. i am so sad. Holly was an inspirational person, colleague and friend. May her memory be a blessing.

Honored to be part of the 100th Class of Guggenheim Fellows for this award in the category of Medicine and Health. I plan to write a book on healthcare, excited to share.

Congratulations to Jessie Holtzman and Christopher Barnett MD, MPH, FACC for great work and a Blue Ribbon! UCSF Cardiology #ucsfqualityimprovement

Great to work with my UCSF Department of Medicine colleagues on this work, illustrating the importance of safety and effectiveness data before clinical use and ideally, before FDA Medical Devices approval.